We support biotech companies across Europe developing new therapeutics.
Biovance Capital Fund I is a biotech fund up to € 60M supported by the European Investment Fund, Caixa Capital, and others. The fund will invest in early-stage biotech companies across Europe and plans to start activities by the end of 2023.Know more
Biovance Capital works closely with entrepreneurs to build leading companies with transformative treatments for patients in need. We target seed and Series A rounds and typically bring additional investors to add value and mitigate risk.
We have developed a wide network across Europe that includes research institutes, incubators and accelerators. Through this network, we have access to a rich pipeline of potential investments.
Biovance Capital Partners is set to manage a new fund up to 60 million euros supported by the European Investment Fund (EIF)...